Sign in
CompletedPhase 4

A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery

Key facts

Who runs it
Ocumension Therapeutics (Shanghai) Co., Ltd
Where
China2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
263 people enrolled
Started
28 Oct 2021
Ended
14 Dec 2023
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Dexycu
Record updated
3 September 2025

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Subjects must be able to understand and sign the informed consent form and be able to follow the study procedures
  • Male or female subjects over 40 years of age who are scheduled to undergo cataract phacoemulsification surgery combined with intraocular lens implantation

Who cannot take part

  • Have high intraocular pressure, with an IOP(intraocular pressure) of > 21 mmHg in the test eye at screening, regardless of whether receiving anti-glaucoma monotherapy therapy
  • Known hypersensitivity to dexamethasone or any component of the Dexycu
  • History of intraocular inflammation of any cause in either eye, presence of corneal abnormalities or malnutrition
  • Posterior capsule rupture or lens dislocation, anterior vitreal membrane rupture, vitreous prolapse and intraoperative floppy iris syndrome during cataract surgery
  • Other conditions that the investigator considers inappropriate to participate the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective, real-world study aimed to evaluate the efficacy and safety of Dexycu in treating postoperative inflammation of cataracts.

The 2 groups in the trial

  • Study GroupTreatment being tested

    Single injection of DEXYCU in the treatment eye after cataract surgery.

    Treatment: Dexycu

  • Control GroupNo study treatment, for comparison

    The clinical routine treatment after cataract surgery was adopted without intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Real-world Study to Evaluate the Efficacy and Safety of 9% Dexamethasone Intraocular Injection for the Treatment of Inflammation Associated With Cataract Surgery
Record updated
3 September 2025